State WV
Clinical Trials in West Virginia
West Virginia is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in West Virginia and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in West Virginia
Frequently Asked Questions — Clinical Trials in West Virginia
How many clinical trials are currently recruiting in West Virginia?
ClinicalMetric currently tracks 49 actively recruiting clinical trials with at least one location in West Virginia. The total number of registered studies—including active but not currently enrolling trials—is 49. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in West Virginia?
West Virginia hosts clinical trials across a broad range of medical conditions, including Acute Ischemic Stroke, HIV Infections, Stage IIIB Lung Cancer AJCC v8, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout West Virginia serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in West Virginia?
To join a clinical trial in West Virginia, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in West Virginia maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in West Virginia
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT07007312 Phase 3
Recruiting
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With...
Condition
Acute Myeloid Leukemia (AML)
Enrollment
1,300 pts
Location
United States, Czechia, France
Sponsor
Kura Oncology, Inc.
NCT05705999 N/A
Recruiting
Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT, a Double-bli...
Condition
Tourette Syndrome
Enrollment
20 pts
Location
United States
Sponsor
West Virginia University
NCT06112418 N/A
Recruiting
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Pr...
Condition
Diabetes Mellitus, Type 2
Enrollment
7,500 pts
Location
United States
Sponsor
Cleerly, Inc.
NCT06237868 N/A
Recruiting
rTMS Over the Dorsolateral Prefrontal Cortex for the Treatment of Impulse Contro...
Condition
Impulse Control Disorder
Enrollment
20 pts
Location
United States
Sponsor
West Virginia University
NCT07174310 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in ...
Condition
Parkinson's Disease
Enrollment
900 pts
Location
United States, Australia, Austria
Sponsor
Hoffmann-La Roche
NCT05636176 Phase 3
Recruiting
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People...
Condition
Heart Failure
Enrollment
5,600 pts
Location
United States, Argentina, Australia
Sponsor
Novo Nordisk A/S
NCT07082738 Phase 2
Recruiting
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Ve...
Condition
Chronic Obstructive Pulmonary Disease (COPD)
Enrollment
987 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT06112340 Phase 2, Phase 3
Recruiting
Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to ...
Condition
Thyroid Eye Disease
Enrollment
75 pts
Location
United States
Sponsor
Sling Therapeutics, Inc.
NCT07198074 Phase 3
Recruiting
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Ca...
Condition
Advanced Endometrial Carcinoma
Enrollment
255 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT02323399 Phase 4
Recruiting
Study to Determine the Pharmacokinetics and Pharmacodynamic Effects of Phenyleph...
Condition
Hypotension
Enrollment
100 pts
Location
United States
Sponsor
West-Ward Pharmaceutical
NCT06481904 N/A
Recruiting
Registry for Stage 2 Type 1 Diabetes
Condition
Type 1 Diabetes
Enrollment
200 pts
Location
United States
Sponsor
Sanofi
NCT03911700 N/A
Recruiting
Prophylactic Reinforcement of Ventral Abdominal Incisions Trial
Condition
Open Midline Laparotomy
Enrollment
477 pts
Location
United States, Austria, Belgium
Sponsor
C. R. Bard
NCT01804686 Phase 3
Recruiting
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Condition
Chronic Lymphocytic Leukemia
Enrollment
700 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
NCT05671510 Phase 3
Recruiting
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhib...
Condition
Non Small Cell Lung Cancer
Enrollment
630 pts
Location
United States, Australia, Belgium
Sponsor
OncoC4, Inc.
NCT05537896 Phase 2
Recruiting
Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patient...
Condition
Hematological Malignancy
Enrollment
55 pts
Location
United States
Sponsor
West Virginia University
NCT06602479 Phase 2
Recruiting
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo i...
Condition
Migraine
Enrollment
488 pts
Location
United States, Czechia, Denmark
Sponsor
AbbVie
NCT02932150 Phase 2
Recruiting
Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chro...
Condition
Chronic Hepatitis B
Enrollment
150 pts
Location
United States, Belgium, Canada
Sponsor
Gilead Sciences
NCT07115940 N/A
Recruiting
Medical Management With Endovascular Thrombectomy Versus Medical Management Alon...
Condition
Acute Ischemic Stroke
Enrollment
408 pts
Location
United States
Sponsor
Amrou Sarraj
NCT06072443 N/A
Recruiting
AURORA Study-A Transformative Approach to Support PrEP Medication Persistence
Condition
HIV Infections
Enrollment
105 pts
Location
United States
Sponsor
WV Health Right, Inc.
NCT07473778 N/A
Recruiting
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
Condition
HIV Infections
Enrollment
3,000 pts
Location
United States
Sponsor
Gilead Sciences
NCT06770582 Phase 2
Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Ther...
Condition
Non-Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
160 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT06498635 Phase 3
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After ...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
306 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06246916 Phase 3
Recruiting
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Partic...
Condition
Melanoma
Enrollment
560 pts
Location
United States, Canada
Sponsor
Regeneron Pharmaceuticals
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,000 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
Page 1 of 2 — 49 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology